FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Alan Hatfield

Research Profile

Procedures

Concepts & Ideas

Physiology

Disease Progression

Chemicals & Drugs

Disorders

Co-author Network

Publications

TOP 3
Edith A Perez; Francois J Geoffroy; Shauna Hillman; Elizabeth A Johnson; Gist Henry Farr; Henry D Tazelarr; Alan K Hatfield; James E Krook; James A Maillard; Ralph Levitt; Randolph S Marks
Phase II study of oral etoposide and intravenous paclitaxel in extensive-stage small cell lung cancer.
James R Jett; Alan K Hatfield; Shauna Hillman; Michael D Bauman; James A Mailliard; John W Kugler; Roscoe F Morton; Randolph S Marks; Ralph Levitt
Alternating chemotherapy with etoposide plus cisplatin and topotecan plus paclitaxel in patients with untreated, extensive-stage small cell lung carcinoma: a phase II trial of the North Central Cancer Treatment Group.
Harry J Long; Sandra Rayson; Karl C Podratz; Samir Abu-Ghazaleh; Vera J Suman; Lynn C Hartmann; Ralph Levitt; Suresh Nair; Alan K Hatfield; James A Knost
Long-term survival of patients with advanced/recurrent carcinoma of cervix and vagina after neoadjuvant treatment with methotrexate, vinblastine, doxorubicin, and cisplatin with or without the addition of molgramostim, and review of the literature.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Alan Hatfield (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2004: Edith A Perez; Francois J Geoffroy; Shauna Hillman; Elizabeth A Johnson; Gist Henry Farr; Henry D Tazelarr; Alan K Hatfield; James E Krook; James A Maillard; Ralph Levitt; Randolph S Marks
Phase II study of oral etoposide and intravenous paclitaxel in extensive-stage small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 2004;44(3):347-53.
2003: James R Jett; Alan K Hatfield; Shauna Hillman; Michael D Bauman; James A Mailliard; John W Kugler; Roscoe F Morton; Randolph S Marks; Ralph Levitt
Alternating chemotherapy with etoposide plus cisplatin and topotecan plus paclitaxel in patients with untreated, extensive-stage small cell lung carcinoma: a phase II trial of the North Central Cancer Treatment Group.
Cancer 2003;97(10):2498-503.
2002: Harry J Long; Sandra Rayson; Karl C Podratz; Samir Abu-Ghazaleh; Vera J Suman; Lynn C Hartmann; Ralph Levitt; Suresh Nair; Alan K Hatfield; James A Knost
Long-term survival of patients with advanced/recurrent carcinoma of cervix and vagina after neoadjuvant treatment with methotrexate, vinblastine, doxorubicin, and cisplatin with or without the addition of molgramostim, and review of the literature.
American journal of clinical oncology 2002;25(6):547-51.
2002: Edith A Perez; L Geeraerts; Vera J Suman; Alex A. Adjei; Andre T Baron; Alan K Hatfield; Nita Maihle; John C Michalak; Steven A Kuross; John W Kugler; Jacqueline M Lafky; James N Ingle
A randomized phase II study of sequential docetaxel and doxorubicin/cyclophosphamide in patients with metastatic breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13(8):1225-35.
2001: Bobbie S Gostout; Lynn C Hartmann; Vera J Suman; Nancy E Fay; J A Jefferies; Roscoe F Morton; Thomas A Gaffey; Gist Henry Farr; Loren K Tschetter; Samir Abu-Ghazaleh; Mary M Gallenberg; Alan K Hatfield
A randomized trial of interferon-alpha in cervical dysplasia.
International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 2001;74(2):207-10.
2001: Jeff A Sloan; Charles L Loprinzi; J A Laurine; Paul J Novotny; Delfino Vargas-Chanes; James E Krook; Michael J O'Connell; John W Kugler; Maria Tria Tirona; Carl G Kardinal; Martin Wiesenfeld; Loren K Tschetter; Alan K Hatfield; Paul L Schaefer
A simple stratification factor prognostic for survival in advanced cancer: the good/bad/uncertain index.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(15):3539-46.
2001: Jan C Buckner; Paula J Schomberg; William L McGinnis; Terrence L Cascino; Bernd W Scheithauer; Judith R O'Fallon; Roscoe F Morton; Steven A Kuross; James A Mailliard; Alan K Hatfield; J T Cole; P D Steen; Albert M Bernath
A phase III study of radiation therapy plus carmustine with or without recombinant interferon-alpha in the treatment of patients with newly diagnosed high-grade glioma.
Cancer 2001;92(2):420-33.
2001: John H Edmonson; Vera J Suman; Robert J Dalton; W C Bro; Mary M Gallenberg; Harry J Long; Ralph Levitt; Alan K Hatfield; James E Krook; James A Mailliard; JB Gerstner
Comparison of conventional dose and double dose carboplatin in patients receiving cyclophosphamide plus carboplatin for advanced ovarian carcinoma: a North Central Cancer Treatment Group Study.
Cancer investigation 2001;19(6):597-602.
2000: Henry C Pitot; James A Knost; Michelle R Mahoney; J Kugler; James E Krook; Alan K Hatfield; Daniel J Sargent; Richard M Goldberg
A North Central Cancer Treatment Group Phase II trial of 9-aminocamptothecin in previously untreated patients with measurable metastatic colorectal carcinoma.
Cancer 2000;89(8):1699-705.
2000: Patrick A Burch; M Block; Georgene Schroeder; John W Kugler; Daniel J Sargent; Theodore A Braich; James A Mailliard; John C Michalak; Alan K Hatfield; K Wright; Steven A Kuross
Phase III evaluation of octreotide versus chemotherapy with 5-fluorouracil or 5-fluorouracil plus leucovorin in advanced exocrine pancreatic cancer: a North Central Cancer Treatment Group study.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(9):3486-92.
2000: J J Weitz; RF Marschke; Jeff A Sloan; JP Grill; James R Jett; James A Knost; Alan K Hatfield; D W Zenk; W W Bate; Paul L Schaefer
A randomized phase II trial of two schedules of topotecan for the treatment of advanced stage non-small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 2000;28(2):157-62.
2000: Edith A Perez; David W Hillman; Philip J Stella; James E Krook; Lynn C Hartmann; Tom R Fitch; Alan K Hatfield; James A Mailliard; Suresh Nair; Carl G Kardinal; James N Ingle
A phase II study of paclitaxel plus carboplatin as first-line chemotherapy for women with metastatic breast carcinoma.
Cancer 2000;88(1):124-31.
1998: Edward T. Creagan; Michael H Veeder; Vera J Suman; Patrick A Burch; William J Maples; Paul L Schaefer; DM Pfeifle; Robert J Dalton; Alan K Hatfield; Michael A Poon
A phase II study of high-dose cimetidine and the combination 5-fluorouracil, interferon alpha-2A, and leucovorin in advanced renal cell adenocarcinoma.
American journal of clinical oncology 1998;21(5):475-8.
1997: Richard M Goldberg; Alan K Hatfield; M Kahn; Daniel J Sargent; James A Knost; Michael J O'Connell; James E Krook; J A Maillard; Martin Wiesenfeld; Paul L Schaefer; Maria Tria Tirona; CG Moertel
Prospectively randomized North Central Cancer Treatment Group trial of intensive-course fluorouracil combined with the l-isomer of intravenous leucovorin, oral leucovorin, or intravenous leucovorin for the treatment of advanced colorectal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(11):3320-9.
1997: Neil Ellison; Charles L Loprinzi; J Kugler; Alan K Hatfield; A Miser; Jeff A Sloan; Donald B Wender; Kendrith M Rowland; R Molina; Terrence L Cascino; Allen M Vukov; H S Dhaliwal; C Ghosh
Phase III placebo-controlled trial of capsaicin cream in the management of surgical neuropathic pain in cancer patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(8):2974-80.
1997: James N Ingle; Patricia A. Johnson; Vera J Suman; JB Gerstner; James A Mailliard; John K Camoriano; Dean H Gesme; Charles L Loprinzi; Alan K Hatfield; Lynn C Hartmann
A randomized phase II trial of two dosage levels of letrozole as third-line hormonal therapy for women with metastatic breast carcinoma.
Cancer 1997;80(2):218-24.
1997: Charles L Loprinzi; C Ghosh; John K Camoriano; J Sloan; P D Steen; John C Michalak; Paul L Schaefer; Paul J Novotny; JB Gerstner; D F White; Alan K Hatfield; Susan K Quella
Phase III controlled evaluation of sucralfate to alleviate stomatitis in patients receiving fluorouracil-based chemotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(3):1235-8.
1994: Charles L Loprinzi; A M Bernath; Daniel J Schaid; J A Malliard; L M Athmann; John C Michalak; Loren K Tschetter; Alan K Hatfield; Roscoe F Morton
Phase III evaluation of 4 doses of megestrol acetate as therapy for patients with cancer anorexia and/or cachexia.
Oncology 1994;51 Suppl 1():2-7.
1994: Charles L Loprinzi; John C Michalak; Susan K Quella; Judith R O'Fallon; Alan K Hatfield; R A Nelimark; A M Dose; T Fischer; C Johnson; N E Klatt
Megestrol acetate for the prevention of hot flashes.
The New England journal of medicine 1994;331(6):347-52.
1994: James N Ingle; J F Foley; James A Mailliard; James E Krook; Lynn C Hartmann; S H Jung; Michael H Veeder; Dean H Gesme; Alan K Hatfield; Richard M Goldberg
Randomized trial of cyclophosphamide, methotrexate, and 5-fluorouracil with or without estrogenic recruitment in women with metastatic breast cancer.
Cancer 1994;73(9):2337-43.
1993: Dean H Gesme; J R Jett; D D Schreffler; J Q Su; James A Mailliard; J F Foley; James E Krook; A W Maksymiuk; Alan K Hatfield; Larry P Ebbert
A randomized phase II trial of amonafide or trimetrexate in patients with advanced non-small cell lung cancer. A trial of the North Central Cancer Treatment Group.
Cancer 1993;71(9):2723-6.
1993: Charles L Loprinzi; John C Michalak; Daniel J Schaid; James A Mailliard; L M Athmann; Richard M Goldberg; Loren K Tschetter; Alan K Hatfield; Roscoe F Morton
Phase III evaluation of four doses of megestrol acetate as therapy for patients with cancer anorexia and/or cachexia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(4):762-7.